30-days effects of vildagliptin on vascular function, plasma viscosity, inflammation, oxidative stress, and intestinal peptides on drug-naïve women with diabetes and obesity: a randomized head-to-head metformin-controlled study
Authors:
- Alessandra SchiapaccassaASAlessandra Schiapaccassa
- Priscila A. MaranhãoPMPriscila A. Maranhão
- Maria das Graças Coelho de SouzaMSMaria das Graças Coelho de Souza
- Diogo G. PanazzoloDPDiogo G. Panazzolo
- José Firmino Nogueira NetoJNJosé Firmino Nogueira Neto
- Eliete BouskelaEliete Bouskela
- Luiz Guilherme Kraemer-AguiarLuiz Guilherme Kraemer-Aguiar
Open Access
- 23 August 2019
- journal article
- research article
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 11 (1) , 1-9
Abstract
Background: Obesity is the main risk factor for diabetes and excessive visceral fat triggers low-grade inflammatory process, mediated by activation and release of cytokines and high flow of free fatty acids that contribute to insulin resistance, increased oxidative stress, and impaired endothelial function. Metformin and vildagliptin have known vasculoprotective actions, but the value of these drugs on drug-naïve diabetic patients during 30 days use warrants investigation. Our purpose was to observe their effects on endothelial function, oxidative stress, inflammatory biomarkers, and plasma viscosity. Methods: 38 women with obesity and type 2 diabetes drug-naïve, aged between 19 and 50 years, BMI ≥ 30 kg/m2, were recruited and subjected to measurements of endothelial function, nutritive skin microvascular reactivity, plasma viscosity, inflammatory and oxidative stress biomarkers at baseline and randomized 1:1 to ingest metformin (850 mg twice/day) or vildagliptin (50 mg twice/day) during 30 days, and then, re-evaluated. Results: No differences between groups were noticed at baseline. After treatment, vildagliptin promoted an improvement on endothelial-dependent and -independent vasodilatations, at arteriole level, while metformin resulted in improved nutritive microvascular reactivity, at the capillary level. Intragroup analysis showed that vildagliptin reduced insulin, C-peptide and oxidized LDL, and increased adiponectin and glucagon-like peptide-1 while metformin reduced weight, plasma glucose, total cholesterol, HDL-c, LDL-c, and dipeptidyl peptidase-4 activity, with an unexpected increase on tumor necrosis factor-α. No significant difference in plasma viscosity was noted. Conclusions: In the vascular beds investigated, both drugs used for only 30 days improved endothelial function, through distinct, and possibly, complementary mechanisms on drug-naïve diabetic women. Trial Registration ClinicalTrials.gov: NCT01827280Keywords
Funding Information
- Novartis S.A. (CLAF237ABR04T)
This publication has 30 references indexed in Scilit:
- Cardiovascular Biology of the Incretin SystemEndocrine Reviews, 2012
- Endothelium-derived hyperpolarizing factor and diabetesWorld Journal of Cardiology, 2011
- Skin microcirculatory dysfunction is already present in normoglycemic subjects with metabolic syndromeMetabolism, 2008
- Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent PathwaysCirculation, 2008
- Effect of postprandial hyperglycaemia on blood viscosity in aged patients suffering from type 2 diabetes as compared with healthy volunteersBlood Coagulation & Fibrinolysis, 2007
- Metformin Increases Blood Flow and Forearm Glucose Uptake in a Group of Non-obese Type 2 Diabetes PatientsHormone and Metabolic Research, 2006
- Metformin Improves Endothelial Vascular Reactivity in First-Degree Relatives of Type 2 Diabetic Patients With Metabolic Syndrome and Normal Glucose ToleranceDiabetes Care, 2006
- The biology of incretin hormonesCell Metabolism, 2006
- Metformin improves endothelial function in patients with metabolic syndromeJournal of Internal Medicine, 2005
- Effect of l-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humansJACC, 1994